Stay updated on Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.

Latest updates to the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe page shows a minor revision update from v3.3.1 to v3.3.2, with no changes to study data, eligibility, contacts, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoChange DetectedThe revision label updated from v3.2.0 to v3.3.1 with no substantive changes to the study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check24 days agoChange DetectedAdded branding references for H. Lee Moffitt Cancer Center and a 'Helpful Links Provided by' section. Removed the NIH operating-status notice from the page.SummaryDifference0.5%

- Check38 days agoChange DetectedNo significant changes were detected on the Study Details page for NCT02638090. The content appears unchanged.SummaryDifference0.4%

- Check67 days agoChange DetectedCore page metadata updated: Last Update Posted is now listed as 'Estimated' and Revision upgraded from v3.0.2 to v3.2.0.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page header now shows an estimated last update time and a new revision version v3.1.0, replacing the previous Last Update Posted and Revision: v3.0.2.SummaryDifference0.1%

Stay in the know with updates to Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.